The Clinical and Economic Impact of Employees Who Are Care Partners of Patients with Multiple Sclerosis by Disease Severity
暂无分享,去创建一个
[1] G. Pardo,et al. The Association Between Persistence and Adherence to Disease-Modifying Therapies and Healthcare Resource Utilization and Costs in Patients With Multiple Sclerosis , 2022, Journal of health economics and outcomes research.
[2] Daniel M. Hartung,et al. The Economic Burden of Multiple Sclerosis in the United States , 2022, Neurology.
[3] J. Chojdak-Łukasiewicz,et al. Adherence to Therapy in Patients with Multiple Sclerosis—Review , 2022, International journal of environmental research and public health.
[4] P. Maguire,et al. Caregiver Burden in Multiple Sclerosis: Recent Trends and Future Directions , 2020, Current Neurology and Neuroscience Reports.
[5] P. Sørensen,et al. Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosis , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.
[6] M. Pereira,et al. Quality of life in patients with multiple sclerosis: A study with patients and caregivers. , 2019, Disability and health journal.
[7] H. Middelkoop,et al. Caregiver strain among life partners of persons with mild disability due to relapsing-remitting multiple sclerosis. , 2019, Multiple sclerosis and related disorders.
[8] P. Maguire,et al. Beyond care burden: associations between positive psychological appraisals and well-being among informal caregivers in Europe , 2019, Quality of Life Research.
[9] C. Isaac,et al. The Relational Impact of Multiple Sclerosis: An Integrative Review of the Literature Using a Cognitive Analytic Framework , 2017, Journal of Clinical Psychology in Medical Settings.
[10] H. Zucker,et al. A Call to Preventive Action by Health Care Providers and Policy Makers to Support Caregivers , 2016, Preventing chronic disease.
[11] Paolo Confalonieri,et al. Low quality of life and psychological wellbeing contrast with moderate perceived burden in carers of people with severe multiple sclerosis , 2016, Journal of Neurological Sciences.
[12] A. Lutterotti,et al. Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study , 2016, PloS one.
[13] R. Marrie,et al. Care Partners and Multiple Sclerosis: Differential Effect on Men and Women. , 2015, International journal of MS care.
[14] É. Bayen,et al. Patterns of Objective and Subjective Burden of Informal Caregivers in Multiple Sclerosis , 2015, Behavioural neurology.
[15] Deborah M. Miller,et al. Who is Taking Care of the Caregiver? , 2015, Journal of patient experience.
[16] M. Duh,et al. Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple sclerosis , 2015, Journal of medical economics.
[17] Patricia Eckardt,et al. Caregivers of Older Persons With Multiple Sclerosis: Determinants of Health-Related Quality of Life , 2015, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.
[18] Lynda Hillman. Caregiving in multiple sclerosis. , 2013, Physical medicine and rehabilitation clinics of North America.
[19] A. Goren,et al. Self-reported burden among caregivers of patients with multiple sclerosis. , 2012, International journal of MS care.
[20] Frauke Zipp,et al. Neurodegeneration in multiple sclerosis: novel treatment strategies , 2012, Expert review of neurotherapeutics.
[21] D. Sobieraj,et al. Dosing frequency and medication adherence in chronic disease. , 2012, Journal of managed care pharmacy : JMCP.
[22] H. Birnbaum,et al. Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US , 2012, Journal of medical economics.
[23] M. Boakye,et al. Socioeconomic Trends in Hospitalization for Multiple Sclerosis , 2010, Neuroepidemiology.
[24] F. Patti. Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence , 2010, Patient preference and adherence.
[25] M. Dubinsky,et al. Effect of medication dosing frequency on adherence in chronic diseases. , 2009, The American journal of managed care.
[26] H. Birnbaum,et al. Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs* , 2009, Current medical research and opinion.
[27] D. Aarsland,et al. Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[28] H. Young,et al. Is Caregiving a Risk Factor for Illness? , 2004 .
[29] E. Oster,et al. Cost of Stress Urinary Incontinence , 2004, PharmacoEconomics.
[30] H. Birnbaum,et al. The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US , 2012, PharmacoEconomics.
[31] J. Opara,et al. Burden and quality of life in caregivers of persons with multiple sclerosis. , 2012, Neurologia i neurochirurgia polska.
[32] E. Oster,et al. Cost of stress urinary incontinence: a claims data analysis. , 2004, PharmacoEconomics.